Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.32 - $0.62 $361,367 - $700,149
-1,129,273 Reduced 35.54%
2,048,182 $1.27 Million
Q2 2023

Aug 14, 2023

BUY
$0.57 - $1.08 $818,118 - $1.55 Million
1,435,296 Added 82.39%
3,177,455 $1.91 Million
Q1 2023

May 15, 2023

SELL
$0.66 - $1.29 $208,024 - $406,592
-315,188 Reduced 15.32%
1,742,159 $1.3 Million
Q4 2022

Feb 14, 2023

BUY
$1.1 - $2.45 $1.16 Million - $2.59 Million
1,057,330 Added 105.73%
2,057,347 $2.55 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.32 $625,532 - $1.06 Million
319,149 Added 46.87%
1,000,017 $2.06 Million
Q2 2022

Aug 15, 2022

SELL
$2.27 - $4.86 $627,434 - $1.34 Million
-276,403 Reduced 28.87%
680,868 $1.89 Million
Q1 2022

May 16, 2022

BUY
$3.69 - $5.65 $689,708 - $1.06 Million
186,913 Added 24.26%
957,271 $4.18 Million
Q4 2021

Feb 14, 2022

SELL
$5.37 - $7.07 $760,665 - $1 Million
-141,651 Reduced 15.53%
770,358 $4.25 Million
Q3 2021

Nov 15, 2021

SELL
$5.54 - $7.51 $1.41 Million - $1.91 Million
-254,340 Reduced 21.81%
912,009 $5.64 Million
Q2 2021

Aug 16, 2021

SELL
$7.78 - $11.4 $6.24 Million - $9.15 Million
-802,239 Reduced 40.75%
1,166,349 $9.91 Million
Q1 2021

May 17, 2021

SELL
$5.12 - $8.48 $1.35 Million - $2.24 Million
-264,529 Reduced 11.85%
1,968,588 $15.6 Million
Q4 2020

Feb 16, 2021

SELL
$3.16 - $7.03 $6.36 Million - $14.2 Million
-2,013,334 Reduced 47.41%
2,233,117 $13 Million
Q3 2020

Nov 16, 2020

SELL
$3.26 - $4.73 $2.54 Million - $3.69 Million
-779,674 Reduced 15.51%
4,246,451 $14.4 Million
Q2 2020

Aug 14, 2020

BUY
$1.58 - $4.63 $4.42 Million - $12.9 Million
2,795,066 Added 125.28%
5,026,125 $23.2 Million
Q1 2020

May 14, 2020

SELL
$1.44 - $3.02 $325,392 - $682,420
-225,967 Reduced 9.2%
2,231,059 $3.53 Million
Q4 2019

Feb 14, 2020

SELL
$2.25 - $3.07 $3.42 Million - $4.67 Million
-1,521,552 Reduced 38.24%
2,457,026 $6.73 Million
Q3 2019

Nov 14, 2019

BUY
$2.67 - $3.65 $2.28 Million - $3.12 Million
855,638 Added 27.4%
3,978,578 $11.7 Million
Q2 2019

Aug 15, 2019

BUY
$2.6 - $4.21 $7.62 Million - $12.3 Million
2,931,413 Added 1530.55%
3,122,940 $8.96 Million
Q2 2019

Aug 14, 2019

SELL
$2.6 - $4.21 $8.11 Million - $13.1 Million
-3,119,928 Reduced 94.22%
191,527 $2.74 Million
Q1 2019

May 14, 2019

BUY
$3.05 - $4.34 $578,100 - $822,607
189,541 Added 6.07%
3,311,455 $13.9 Million
Q4 2018

Feb 14, 2019

BUY
$2.82 - $4.67 $594,692 - $984,828
210,884 Added 7.24%
3,121,914 $9.71 Million
Q3 2018

Nov 14, 2018

BUY
$1.45 - $6.15 $717,870 - $3.04 Million
495,083 Added 20.49%
2,911,030 $12.7 Million
Q2 2018

Aug 14, 2018

SELL
$1.65 - $2.5 $233,250 - $353,410
-141,364 Reduced 5.53%
2,415,947 $3.99 Million
Q1 2018

May 15, 2018

BUY
$1.25 - $2.65 $3.2 Million - $6.78 Million
2,557,311 New
2,557,311 $4.73 Million
Q4 2017

Feb 14, 2018

SELL
$1.23 - $2.3 $86,102 - $161,004
-70,002 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$1.95 - $2.25 $136,503 - $157,504
70,002
70,002 $158,000

Others Institutions Holding AFMD

About Affimed N.V.


  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $520M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.